Trial Profile

A phase I study of oral dissolving strips for the delivery of Isoniazid in children and adults.

Status: Planning

Phase of Trial: Phase I

Latest Information Update: 06 Oct 2017

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Isoniazid (Primary)
Indications Tuberculosis
Focus Adverse reactions; Pharmacokinetics

Most Recent Events

06 Oct 2017 New trial record
03 Oct 2017 According to an Oak Therapeutics media release, the Oak therapeutics received Small Business Innovative Research (SBIR) contract from the National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID) for this Phase I project.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com